Nasolabial Folds, Wrinkles
8
2
3
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
100%
2 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
A Prospective Clinical Investigation of DMFI300 for Treating Nasolabial Folds
A Prospective Clinical Investigation of DMFI150 for Treating Nasolabial Folds
Study of DIOSHA S Lido Injection vs. YOUTHFILL Fine With Lidocaine in Treating Moderate to Severe Nasolabial Folds
Real-Life Evaluation of the HA Dermal Filler ESTYME® LIFT
Study of JTM104 Injection vs. Juvederm in Treating Moderate to Severe Nasolabial Folds
Purpose of This Study is the Demonstration of Safety and Efficacy of the Dermal Fillers DXP01 Temporary Improvement of Moderate to Severe Nasolabial Folds
TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds
TEOSYAL® RHA Ultra Deep and Perlane-L® for the Correction of Nasolabial Folds